Selvita Revenue and Competitors

Kraków, Poland

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Selvita's estimated annual revenue is currently $104.3M per year.(i)
  • Selvita's estimated revenue per employee is $124,000

Employee Data

  • Selvita has 841 Employees.(i)
  • Selvita grew their employee count by 3% last year.

Selvita's People

NameTitleEmail/Phone
1
VP Integrated Drug DiscoveryReveal Email/Phone
2
Head the Biochemistry LaboratoryReveal Email/Phone
3
Head Analytical LaboratoryReveal Email/Phone
4
Head in-vitro Pharmacology LaboratoryReveal Email/Phone
5
VP Sales Drug Development Europe & AsiaReveal Email/Phone
6
VP ChemistryReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
EVP, Chief Scientific OfficerReveal Email/Phone
9
Director Pharmacology, Integrated Drug DiscoveryReveal Email/Phone
10
Director the Poznan DivisionReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.7M177-12%N/AN/A
#2
$12.1M15621%N/AN/A
#3
$10.7M1388%N/AN/A
#4
$0.3M4-20%N/AN/A
#5
$100.7M129910%N/AN/A
#6
$8.3M1071%N/AN/A
#7
$8.5M1108%N/AN/A
#8
$104.3M8413%N/AN/A
#9
$5.6M7233%N/AN/A
#10
$8.7M11238%N/AN/A
Add Company

What Is Selvita?

Selvita is an integrated service provider aiming to deliver a set of comprehensive solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development.

keywords:N/A

N/A

Total Funding

841

Number of Employees

$104.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Selvita News

2022-03-30 - Selvita sums up 2021 and announces Development Strategy ...

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope...

2022-03-30 - Selvita S.A.'s (WSE:SLV) large institutional owners must be happy as stock continues to impress, up 15% over the past week

We can see that Selvita does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$99M10108%N/A
#2
$102.7M101212%N/A
#3
$562.1M352212%N/A